Gujarat Themis Biosyn Share Price

Need a serious fall in Indian markets before I start buying

Nykaa Q3 FY25 results: Net profit rises 61% to Rs 26 crore, revenue up 27%

GIFT City spillover boosts Ahmedabad's rise as a trading hub, shows data

Market Crash LIVE: Sensex drops 1,000 pts to 76,300

Market LIVE: SMIDs, Realty, Auto, FMCG,₹ Financials drag up to 3%; Sensex 40

Pursuant to Regulation 39(3) of the SEBI (LODR) Regulation 2015 we would like to inform you that the Registrar and Transfer Agent of the Company i.e. Link Intime India Private Limited has received below mentioned intimation / request(s) for Loss of Share Certificate(s) / issuance of duplicate share certificate(s) from the following shareholder(s):Sr. No. Name Folio No. Cert. No. Number of Shares Dist. No.From Dist. No.To1 WAJIDALI RANGOONWALA W000012 20698 50 2494001 2494050 2 WAJIDALI RANGOONWALA W000012 20699 50 2494051 2494100 We shall issue the duplicate Share Certificate(s) only after the necessary formalities are carried out by the Shareholder(s).This may be taken as compliance under the Listing Regulations.

The Board of Directors at its meeting held today considered and approved the Unaudited Financial Results of the Company for the Quarter ended 31st December 2022. A copy of Unaudited Financial Results of the Company for the Quarter ended 31st December 2022 together with Limited Review Report is enclosed herewith.This may be taken as compliance under the Listing Regulations.

The Board of Directors at its meeting held today considered and approved the Unaudited Financial Results of the Company for the Quarter ended 31st December 2022. <BR> <BR> A copy of Unaudited Financial Results of the Company for the Quarter ended 31st December 2022 together with Limited Review Report is enclosed herewith.<BR> <BR> This may be taken as compliance under the Listing Regulations.<BR>

The Company is scheduling Earning Conference Call on Monday 6th February 2023 at 04:30 p.m. Details of meeting attached below.Note: The schedule of the aforesaid meetings is subject to change. The changes may happen due to exigencies on the part of Fund / Broking House / Company.No Unpublished Price Sensitive Information (UPSI) will be discussed in the meetings/calls.Pursuant to regulation 46(2) of the Listing Regulations aforesaid information shall be disclosed on the website of the company viz. www.gtbl.inThis is for your information and record.

GUJARAT THEMIS BIOSYN LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 03/02/2023 inter alia to consider and approve With respect to the captioned subject please be informed that a meeting of the Board of Directors of Gujarat Themis Biosyn Limited is scheduled to be held on Friday 03rd February 2023 inter alia to consider the Un-audited Standalone Financial Results for the Quarter and nine months ended on 31st December 2022.Further in continuation of our Letter dated 26th December 2022 the Trading Window in respect of dealing in the Companys Securities was closed for all Directors/Designated Employees from the opening of the trading hours on Sunday 1st January 2023 which shall remain closed till the closure of trading hours on 05th February 2023 (both days inclusive) i.e. till the completion of 48 hours after the declaration of financial results as per the policy for prohibition of Insider Trading (the Code) adopted by the Company pursuant to SEBI (Prohibition of Insider Trading) Regulations 2015 as amended from time to time.